A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification

BACKGROUND: Chronic hepatitis B virus (HBV) infection is the major etiology of hepatocellular carcinoma (HCC). However, the mechanism of hepatitis B-related hepatocellular carcinoma (HBV-related HCC) is still unclear. Therefore, understanding the pathogenesis and searching for drugs to treat HBV-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shenghao, Hao, Liyuan, Hu, Xiaoyu, Li, Luya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315056/
https://www.ncbi.nlm.nih.gov/pubmed/37393234
http://dx.doi.org/10.1186/s13027-023-00520-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315056/
https://www.ncbi.nlm.nih.gov/pubmed/37393234
http://dx.doi.org/10.1186/s13027-023-00520-z

Ejemplares similares